1887

Abstract

SUMMARY

The cell growth inhibitory efficacies of preparations of human α and γ interferons (IFNs) have been tested on a variety of human cell lines. Human IFN-γ was found to be more effective at inhibiting the growth of HeLa and U-amnion cells than was human IFN-α. The Daudi cell line, on the other hand, which exhibits a strong anticellular effect in response to treatment with human IFN-α, was found to be relatively insensitive to the anticellular effect of human IFN-γ, as were a variety of other lymphoid cell lines. The inability of the IFN-γ to inhibit the growth of the Daudi cells is paralleled by its inability to induce the synthesis of proteins observed to be synthesized in these cells in response to IFN-α.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-8-1743
1983-08-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/8/JV0640081743.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-8-1743&mimeType=html&fmt=ahah

References

  1. Aguet M. 1980; High affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Nature, London 284:459–461
    [Google Scholar]
  2. Aguet M., Blanchard B. 1981; High affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Virology 115:249–261
    [Google Scholar]
  3. Ankel H., Krishnamurti C., Besancon F., Stefanos S., Falcoff E. 1980; Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells. Proceedings of the National Academy of Sciences, U. S. A 77:2528–2532
    [Google Scholar]
  4. Blalock J. E., Georgiades J. A., Langford M. P., Johnson H. M. 1980; Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cellular Immunology 49:390–394
    [Google Scholar]
  5. Branca A. A., Baglioni C. 1981; Evidence that type I and II interferons have different receptors. Nature, London 294:768–770
    [Google Scholar]
  6. Deley M., Van Damme J., Claeys H., Weening H., Heine J. W., Billiau A., Vermylen C., Desomer P. 1980; Interferon induced in human leukocytes by mitogens: production, partial purification and characterization. European Journal of Immunology 10:877–883
    [Google Scholar]
  7. Dianzani F., Salter L., Fleischman W. R., Zucca M. 1978; Immune interferon activates cells more slowly than does virus induced interferon. Proceedings of the Society for Experimental Biology and Medicine 159:94–97
    [Google Scholar]
  8. Dianzani F., Zucca M., Scuphan A., Georgiades J. A. 1980; Immune and virus induced interferons may activate cells by different derepressional mechanisms. Nature, London 283:400–402
    [Google Scholar]
  9. Farrell P. J., Broeze R. J., Lengyel P. 1979; Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumor cells. Nature, London 271:523–525
    [Google Scholar]
  10. Gresser I., Maury C., Brouty-Boye D. 1972; On the mechanism of the antitumor effect of interferon in mice. Nature, London 239:167–168
    [Google Scholar]
  11. Gresser I., Bandu H. T., Brouty-Boye D. 1974; Interferon and cell division. IX. Interferon resistant L1210 cells: characteristics and origin. Journal of the National Cancer Institute 52:553–559
    [Google Scholar]
  12. Gufta S. L., Rubin B. Y., Holmes S. L. 1979; Interferon action: induction of specific proteins in mouse and human cells by homologous interferons. Proceedings of the National Academy of Sciences, V. S. A 76:4817–4821
    [Google Scholar]
  13. Hovanessian A. G., La Bonnardiere C., Falcoff E. 1980; Action of murine y (immune)-interferon on 11 (fibroblast)-interferon resistant L1210 and embryonal carcinoma cells. Journal of Interferon Research 1:125–135
    [Google Scholar]
  14. Johnson H. M., Stanton G. J., Baron S. 1977; Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro response. Proceedings of the Society for Experimental Biology and Medicine 154:138–143
    [Google Scholar]
  15. Lauappa K. S. 1978; Survey of ATCC stocks of human cell lines for HeLa contamination. In Vitro 14:469–475
    [Google Scholar]
  16. Rubin B. Y., Gupta S. L. 1980a; Interferon-induced proteins in human fibroblasts and development of the antiviral state. Journal of Virology 34:446–454
    [Google Scholar]
  17. Rubin B. Y., Gupta S. L. 1980b; Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proceedings of the National Academy of Sciences, U. S. A 77:5928–5932
    [Google Scholar]
  18. Rubin B. Y., Bartal A. H., Anderson S. L., Millet S. K., Hirshaut Y., Feit C. 1983; The anticellular activity of human y interferon preparations is mediated by the interferon. Journal of Immunology 130:1019–1020
    [Google Scholar]
  19. Stewart W. E. II 1979 The Interferon System New York: Springer-Verlag;
    [Google Scholar]
  20. Wiranowska-Stewart M., Lin L. S., Braude I. A., Stewart W. E. II 1980; Production, partial purification and characterization of human and murine interferons-type II. Molecular Immunology 17:625–633
    [Google Scholar]
  21. Yokota Y., Kishida T., Esaki K., Kawamata J. 1976; Antitumor effects of interferon on transplanted tumors in congenitally athymic nude mice. Biken Journal 19:125–139
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-64-8-1743
Loading
/content/journal/jgv/10.1099/0022-1317-64-8-1743
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error